The fludarabine, cytarabine, and granulocyte colony-stimulating factor (FLAG) chemotherapy regimen is an alternative to anthracycline-based therapy for the treatment of acute myeloid leukemia for patients with pre-existing cardiac disease-Reference-Cited by-同舟云学术

The fludarabine, cytarabine, and granulocyte colony-stimulating factor (FLAG) chemotherapy regimen is an alternative to anthracycline-based therapy for the treatment of acute myeloid leukemia for patients with pre-existing cardiac disease

Published:2016-05-03 Issue:5 Volume:97 Page:471-478
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Saini Lalit¹,Brandwein Joseph¹,Turner Robert¹,Larratt Loree¹,Hamilton Marlene¹,Peters Anthea¹,Wu Cynthia¹,Zhu Nancy¹,Patterson Jeffery M.¹,Bolster Lauren¹,Mant Michael¹,Ritchie Bruce¹,Liew Elena¹,Ghosh Sunita²,Sandhu Irwindeep¹

Affiliation:

1. Division of Hematology; Department of Medicine; University of Alberta; Edmonton AB Canada

2. Department of Medical Oncology; University of Alberta; Edmonton AB Canada

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12757/fullpdf

Reference43 articles.

1. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet;Dohner;Blood,2010

2. The treatment of AML: current status and novel approaches;Burnett;Hematology,2005

3. Treating the elderly patient with acute myelogenous leukemia;Luger;Hematology Am Soc Hematol Educ Program,2010

4. The outcomes and costs of acute myeloid leukemia among the elderly;Menzin;Arch Intern Med,2002

5. A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment;Burnett;Cancer,2007

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of G-CSF in high-leukocyte acute myeloid leukemia is a poor prognostic factor;Hematology;2023-06-06

2. RNA Targeting in Acute Myeloid Leukemia;ACS Pharmacology & Translational Science;2020-10-12

3. A strategy of Day14 bone marrows and early intervention is not superior to a strategy of noDay14 bone marrows and delayed intervention in patients with acute myeloid leukemia;Leukemia & Lymphoma;2019-05-02

4. Myelodysplastic syndromes and acute myeloid leukemias in the elderly;European Journal of Internal Medicine;2018-12